The interactions of dietary tomato powder and soy germ on prostate carcinogenesis in the TRAMP model

Cancer Prevention Research

Volumn 6, Issue 6, 2013, Pages 548-557

  Zuniga, Krystle E ^a   Clinton, Steven K ^b   Erdman, John W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CARCINOGENESIS; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CARCINOGENESIS; PROSTATE EPITHELIUM; PROSTATIC INTRAEPITHELIAL NEOPLASIA; SOYBEAN; THERAPY EFFECT; TOMATO;

EID: 84878883780     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-12-0443     Document Type: Article

References (50)

1. Kummar S, Chen HX, Wright J, Holbeck S, Millin MD, Tomaszewski J, et al. Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements. Nat Rev Drug Discov 2010;9:843-56.
2. Humphrey RW, Brockway-Lunardi LM, Bonk DT, Dohoney KM, Doroshow JH, Meech SJ, et al. Opportunities and challenges in the development of experimental drug combinations for cancer. J Natl Cancer Inst 2011;103:1222-6.
3. Yan L, Spitznagel EL. Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr 2009;89:1155-63.
4. Etminan M, Takkouche B, Caamano-Isorna F. The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev 2004;13:340-5. (Pubitemid 38737456)
5. Engelmann NJ, Clinton SK, Erdman JW Jr. Nutritional aspects of phytoene and phytofluene, carotenoid precursors to lycopene. Adv Nutr 2011;2:51-61.
6. Goetzl MA, Van Veldhuizen PJ, Thrasher JB. Effects of soy phytoestrogens on the prostate. Prostate Cancer Prostatic Dis 2007;10:216-23. (Pubitemid 47351400)
7. Ford NA, Moran NE, Smith JW, Clinton SK, Erdman JW Jr. An interaction between carotene-15,15′-monooxygenase expression and consumption of a tomato or lycopene-containing diet impacts serum and testicular testosterone. Int J Cancer 2012;131:E143-8.
8. Tan HL, Thomas-Ahner JM, Grainger EM, Wan L, Francis DM, Schwartz SJ, et al. Tomato-based food products for prostate cancer prevention: what have we learned? Cancer Metastasis Rev 2010;29:553-68.
9. Canene-Adams K, Lindshield BL, Wang S, Jeffery EH, Clinton SK, Erdman JW Jr. Combinations of tomato and broccoli enhance antitumor activity in dunning r3327-h prostate adenocarcinomas. Cancer Res 2007;67:836-43. (Pubitemid 46192225)
10. Hsu A, Bruno RS, Löhr CV, Taylor AW, Dashwood RH, Bray TM, et al. Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFkB pathway in the noble rat model. J Nutr Biochem 2011;22:502-10.
11. Pannellini T, Iezzi M, Liberatore M, Sabatini F, Iacobelli S, Rossi C, et al. A dietary tomato supplement prevents prostate cancer in TRAMP mice. Cancer Prev Res 2010;3:1284-91.
12. Mossine VV, Chopra P, Mawhinney TP. Interaction of tomato lycopene and ketosamine against rat prostate tumorigenesis. Cancer Res 2008;68:4384-91.
13. Zhou JR, Yu L, Zhong Y, Blackburn GL. Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J Nutr 2003;133:516-21. (Pubitemid 36172909)
14. Zhou JR, Yu L, Zhong Y, Nassr RL, Franke AA, Gaston SM, et al. Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components. Prostate 2002;53:143-53.
15. Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr 1999;129:1628-35. (Pubitemid 29406613)
16. Mentor-Marcel R, Lamartiniere C, Eltoum I, Greenberg N, Elgavish A. Dietary genistein improves survival and reduces expression of osteopontin in the prostate of transgenic mice with prostatic adenocarcinoma (TRAMP). J Nutr 2005;135:989-95. (Pubitemid 40638296)
17. Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavish A. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res 2001;61:6777-82. (Pubitemid 32896500)
18. El Touny LH, Banerjee PP. Akt GSK-3 pathway as a target in genistein-induced inhibition of TRAMP prostate cancer progression toward a poorly differentiated phenotype. Carcinogenesis 2007;28:1710-7. (Pubitemid 47289033)
19. Boileau TW, Liao Z, Kim S, Lemeshow S, Erdman JW Jr, Clinton SK. Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testoster-one-treated rats fed tomato powder, lycopene, or energy-restricted diets. J Natl Cancer Inst 2003;95:1578-86. (Pubitemid 37455925)
20. Talvas J, Caris-Veyrat C, Guy L, Rambeau M, Lyan B, Minet-Quinard R, et al. Differential effects of lycopene consumed in tomato paste and lycopene in the form of a purified extract on target genes of cancer prostatic cells. Am J Clin Nutr 2010;91:1716-24.
21. Hsu A, Bray TM, Helferich WG, Doerge DR, Ho E. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells. Exp Biol Med 2010;235:90- 7.
22. Grainger EM, Schwartz SJ, Wang S, Unlu NZ, Boileau TW, Ferketich AK, et al. A combination of tomato and soy products for men with recurring prostate cancer and rising prostate specific antigen. Nutr Cancer 2008;60:145-54. (Pubitemid 351451270)
23. Klein RD. The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research. Mutat Res 2005;576:111-9. (Pubitemid 40982686)
24. Berman-Booty LD, Sargeant AM, Rosol TJ, Rengel RC, Clinton SK, Chen CS, et al. A review of the existing grading schemes and a proposal for a modified grading scheme for prostatic lesions inTRAMP mice. Toxicol Pathol 2012;40:5-17.
25. Liao Z, Boileau TW, Erdman JW Jr, Clinton SK. Interrelationships among angiogenesis, proliferation, and apoptosis in the tumor microenvironment during N-methyl-N-nitrosourea androgen-induced prostate carcinogenesis in rats. Carcinogenesis 2002;23:1701-11. (Pubitemid 35214956)
26. Zuniga KE, Erdman JW Jr. Combined consumption of soy germ and tomato powders results in altered isoflavone and carotenoid bioavailability in rats. J Agric Food Chem 2011;59:5335-41.
27. Kaplan-Lefko PJ, Chen TM, Ittmann MM, Barrios RJ, Ayala GE, Huss WJ, et al. Pathobiology of autochthonous prostate cancer in a preclinical transgenic mouse model. Prostate 2003;55:219-37. (Pubitemid 36532401)
28. Bowen P, Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, Ghosh L, et al. Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp Biol Med 2002;227:886-93. (Pubitemid 35340343)
29. Van Breemen RB, Xu X, Viana MA, Chen L, Stacewicz-Sapuntzakis M, Duncan C, et al. Liquid chromatography - mass spectrometry of cis- and all-trans-lycopene in human serum and prostate tissue after dietary supplementation with tomato sauce. J Agric Food Chem 2002;50:2214-9. (Pubitemid 34275287)
30. Messina MJ. Emerging evidence on the role of soy in reducing prostate cancer risk. Nutr Rev 2003;61:117-31. (Pubitemid 37255289)
31. Bohn T, Blackwood M, Francis D, Tian Q, Schwartz SJ, Clinton SK. Bioavailability of phytochemical constituents from a novel soy fortified lycopene rich tomato juice developed for targeted cancer prevention trials. Nutr Cancer 2011.
32. Consumer products [Internet]. Available from: http://www.soylife.com/ consumer-products-p3741-en.html.
33. Perabo FG, Von Löw EC, Ellinger J, von Rücker A, Müller SC, Bastian PJ. Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis 2008;11:6-12. (Pubitemid 351250324)
34. Wang J, Eltoum I, Lamartiniere C. Genistein chemoprevention of prostate cancer in TRAMP mice. J Carcinog 2007;6:3.
35. Wang J, Eltoum I, Lamartiniere C. Genistein alters growth factor signaling in transgenic prostate model (TRAMP). Mol Cell Endocrinol 2004;219:171-80. (Pubitemid 38638530)
36. El Touny L, Banerjee P. Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Res 2009;69:3695-703.
37. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 2002;132:3577-84. (Pubitemid 35435031)
38. Hedlund T, Maroni P, Ferucci P, Dayton R, Barnes S, Jones K, et al. Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in caucasian men. J Nutr 2005;135:1400-6. (Pubitemid 40799602)
39. Brössner C, Petritsch K, Fink K, Auprich M, Madersbacher S, Adlercreutz H, et al. Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases. Urology 2004;64:707-11. (Pubitemid 39446048)
40. Guy L, Védrine N, Urpi-Sarda M, Gil-Izquierdo A, Al-Maharik N, Boiteux J, et al. Orally administered isoflavones are present as glucuronides in the human prostate. Nutr Cancer 2008;60:461-8. (Pubitemid 351918538)
41. Hong S, Kim S, Kwon S, Lee J, Chung B. Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia. Yonsei Med J 2002;43:236-41. (Pubitemid 34498427)
42. Messina M, Nagata C, Wu AH. Estimated asian adult soy protein and isoflavone intakes. Nutr Cancer 2006;55:1-12. (Pubitemid 44477039)
43. Lindshield BL, Canene-Adams K, Erdman JW Jr. Lycopenoids: are lycopene metabolites bioactive? Arch Biochem Biophys 2007;458:136-40. (Pubitemid 46215568)
44. Wang S, DeGroff VL, Clinton SK. Tomato and soy polyphenols reduce insulin-like growth factor-I-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase. J Nutr 2003;133:2367-76. (Pubitemid 36841567)
45. Guo Y, Wang S, Hoot D, Clinton S. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. J Nutr Biochem 2007;18:408-17. (Pubitemid 46727041)
46. Kim HS, Bowen P, Chen L, Duncan C, Ghosh L, Sharifi R, et al. Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma. Nutr Cancer 2003;47:40 - 7.
47. Hedlund TE, van Bokhoven A, Johannes WU, Nordeen SK, Ogden LG. Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro. Prostate 2006;66:557-66.
48. Vaishampayan U, Hussain M, Banerjee M, Seren S, Sarkar F, Fontana J, et al. Lycopene and soy isoflavones in the treatment of prostate cancer. Nutr Cancer 2007;59:1-7. (Pubitemid 47549774)
49. U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary guidelines for Americans, 2010. Washington, DC: U.S. Government Printing Office; 2010. Report No.: 7th edition.
50. WCRF Panel. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington (DC): American Institute for Cancer Research; 2007.